We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ULTRAVIST (Bayer Australia Ltd)
Product name
ULTRAVIST
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
220 (255 working days)
Active ingredients
iopromide
Registration type
EOI
Indication
ULTRAVIST is indicated for all angiographic and urographic examinations and for contrast enhancement in computerised tomography.,ULTRAVIST 300 or 370 is indicated for use in contrast-enhanced mammography (CEM) in adults, to visualise known or suspected lesions of the breast as an adjunct to mammography (with or without ultrasound).